Psychiatry and Neurology, Neurology · Orange, CA
NPI
1275614687
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
101 the City Dr S
Orange, CA, 92868
Phone (714) 456-8888
Groups this clinician bills Medicare through
Medicare paid, 2024
$366K
65,769 services
Medicare patients, 2024
120
Average age 68
Drug cost, 2024
$1.4M
1,262 prescriptions
Company payments, 2025
$124
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mimi Sohn was code J0585 (injection, onabotulinumtoxina, 1 unit), 65,340 times for 94 patients. In total Mimi Sohn billed 65,769 services in 10 codes, and Medicare paid $366K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 65,340 | 94 | $4.91 | $321K |
| 64615 Musculoskeletal | Office | 328 | 94 | $101.83 | $33K |
By year: 2022 $306K for 57,196 services; 2023 $358K for 66,463 services; 2024 $366K for 65,769 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mimi Sohn prescribed most often to Medicare patients was Nurtec Odt (Rimegepant Sulfate), with 312 prescriptions and refills. In total Mimi Sohn wrote 1,262 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Nurtec Odt Rimegepant Sulfate | 312 | 366 | 52 | $617K |
| Ubrelvy Ubrogepant | 189 | 266 | 44 | $353K |
| Emgality Pen Galcanezumab-Gnlm | 86 | 181 | 26 | $117K |
| Aimovig Autoinjector Erenumab-Aooe | 85 | 180 | 20 | $125K |
| Ajovy Autoinjector Fremanezumab-Vfrm | 66 | 114 | 16 | $79K |
| Rizatriptan Rizatriptan Benzoate | 58 | 58 | 11 | $1,289 |
| Topiramate Generic | 56 | 78 | Under 11 | $320 |
| Sumatriptan Succinate Generic | 39 | 39 | 11 | $2,534 |
| Tizanidine Hcl Generic | 33 | 33 | Under 11 | $368 |
| Naratriptan Hcl Generic | 31 | 31 | Under 11 | $666 |
| Divalproex Sodium Generic | 22 | 22 | Under 11 | $744 |
| Gabapentin Generic | 22 | 34 | Under 11 | $582 |
| Promethazine Hcl Generic | 21 | 21 | Under 11 | $124 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 18 | 18 | Under 11 | $118 |
| Ajovy Syringe Fremanezumab-Vfrm | 16 | 44 | Under 11 | $30K |
Brand drugs: 809 claims; generic drugs: 453 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mimi Sohn $124 ($124 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $124.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $124 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.